04:54 PM EDT, 08/19/2025 (MT Newswires) -- Alcon ( ALC ) reported Q2 core earnings late Tuesday of $0.76 per diluted share, up from $0.74 a year earlier.

Analysts polled by FactSet expected $0.72.

Net sales for the quarter ended June 30 was $2.58 billion, up from $2.48 billion a year earlier.

Analysts surveyed by FactSet expected $2.62 billion.

The company reiterated its full-year 2025 core EPS guidance of $3.05 to $3.15. Analysts surveyed by FactSet expect $3.12.

The company now expects 2025 revenue of $10.3 billion to $10.4 billion, versus $10.4 billion to $10.5 billion earlier. Analysts surveyed by FactSet expect $10.47 billion.

Alcon ( ALC ) said it launched Tryptyr for dry eye disease in the US. It also entered into an agreement to acquire STAAR Surgical to expand its presence in myopia correction. Financial details of the deal were not disclosed.

Shares of the company fell 7.9% during after-hours activity.

Price: 83.00, Change: -7.12, Percent Change: -7.90